Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pranay Dogra

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Medrxiv : the Preprint Server for Health Sciences|July 24, 2020
Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19Stuart P Weisberg, Thomas Connors, Yun Zhu, et al.
Nature Immunology|November 6, 2020
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrumStuart P Weisberg, Thomas J Connors, Yun Zhu, et al.
Ebiomedicine|July 6, 2025
Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinationsJérémie Decalf, Evangeline Toy, Dongping He, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Medrxiv : the Preprint Server for Health Sciences|July 24, 2020
Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19Stuart P Weisberg, Thomas Connors, Yun Zhu, et al.
Nature Immunology|November 6, 2020
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrumStuart P Weisberg, Thomas J Connors, Yun Zhu, et al.
Ebiomedicine|July 6, 2025
Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinationsJérémie Decalf, Evangeline Toy, Dongping He, et al.
Pageof 4